Navigation Links
Abuse-Deterrent Formulations of Purdue's OxyContin and Endo Pharmaceuticals' Opana ER Have Not Increased PCPs' Comfort When Prescribing These Products for Chronic Pain
Date:7/16/2013

BURLINGTON, Mass., July 16, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite the replacement of Purdue Pharma's OxyContin and Endo Pharmaceuticals' Opana ER with abuse-deterrent formulations, surveyed primary care physicians (PCPs) do not feel more comfortable prescribing these products for the treatment of chronic pain. In contrast, the majority of surveyed pain specialists report that they are more comfortable prescribing OxyContin and Opana ER now that the products feature abuse-deterrent properties.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36784LOGO )

The U.S. Physician & Payer Forum report entitled Chronic Pain: How Will U.S. Payers and Prescribers Shape Market Access for Recently Launched and Emerging Products? also finds that 57 percent and 53 percent of surveyed managed care organization (MCO) directors report that coverage of OxyContin and Opana ER has not changed as a result of the products' reformulation to be abuse-deterrent—suggesting that, in many patients, the cost to reimburse OxyContin and Opana ER may outweigh the advantages of the abuse-deterrent formulations. In cases where a non-abuse-deterrent generic opioid was available, MCO directors are likely to only reimburse an abuse-deterrent product in patients with a history of drug abuse—signaling that emerging abuse-deterrent formulations will still be subject to coverage restrictions.

The report also finds that cost will likewise be an important consideration for prescribing and reimbursement of new chronic pain therapies, most notably for Pfizer's novel anti-NGF therapy tanezumab. Seventy-four percent of surveyed PCPs and 48 percent of surveyed
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid
2. KemPharm Supports Recent FDA Recommendations for Hydrocodone-Containing Compounds and Abuse-Deterrent Opioids
3. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
4. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
5. XCHC Releases Worldwide Growth Guidance For Its Cannabinoid Treatment Centers and Formulations Targeting Critical Human Ailments, Company Acts on Own Guidance
6. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
7. Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval
8. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
9. Biodel Obtains Exclusive License to Aegis Therapeutics Technologies for Development and Commercialization of Glucagon Pharmaceutical Formulations
10. Valeant Pharmaceuticals To Announce 2013 Second Quarter Results On August 7, 2013
11. GW Pharmaceuticals to Report Q3 2013 Results and Host Conference Call on 5 August, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
(Date:8/29/2014)... Diseases largely eradicated in the United States ... declared eliminated in 2000, yet the CDC reports 593 ... incidence in 20 years. In July, California,s ... problem of "epidemic proportions." Across ... preventable diseases—in part because some parents (more than 10 ...
(Date:8/29/2014)... Ohio , Aug. 29, 2014  In ... how to leverage a hospital pharmacy as a strategic ... and national practice leader for Cardinal Health,s Innovation Delivery ... pharmacy care can benefit both hospitals and patients. ... is only one part of their job in a ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4
... GeneXpert(R) System ... ... today announced the U.S. Food & Drug Administration (FDA) categorized,Cepheid,s ... Clinical Laboratory Improvement Amendments (CLIA).,The new test is designed for ...
... Michael J. Fox,Foundation today announced the availability of ... toward transformative treatments and a cure for,Parkinson,s disease., ... researchers through the,Foundation,s Pipeline Programs, five separate initiatives ... drug development pipeline. This includes,early-stage discovery research, translational ...
Cached Medicine Technology:Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 2Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 3Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized 'Moderate Complexity' by FDA 4Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinson's Disease Research 2Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinson's Disease Research 3Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinson's Disease Research 4
(Date:8/30/2014)... medication commonly used to treat gout, before and ... potential complications from this type of surgery, but ... effects, according to a study published by ... online to coincide with its presentation at the ... after cardiac surgery include postpericardiotomy syndrome (the occurrence ...
(Date:8/30/2014)... York, New York (PRWEB) August 30, 2014 ... litigation for transvaginal mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) ... company’s request to sever four cases selected for ... an Order issued on August 18, 2014, U.S. ... District of West Virginia disagrees with Boston Scientific’s ...
(Date:8/30/2014)... WA (PRWEB) August 30, 2014 One of ... this era is the gluten-free diet. Originally meant for sufferers ... become a catchall for people who are looking to get ... However, not only is this kind of information erroneous, it ... health problems because of a drastic change in their ...
(Date:8/30/2014)... OK (PRWEB) August 30, 2014 LiveStreamingFitness.com, a ... well as other healthy lifestyle resources, is proud to announce ... nationwide resources for at home fitness solutions by ABC’s Good ... recent featured story on ABC’s Good Morning America, “Live Streaming ... you can streamline your day by streamlining your workout…to boot ...
(Date:8/30/2014)... WA (PRWEB) August 30, 2014 “In 2013, ... alone,” The Jones Firm says in a recently released article ... “A person was injured in an auto accident every 12 ... 16 minutes,” they continue. “Based on the 2013 statistics, between ... a vehicle collision.” , The threat of an auto accident ...
Breaking Medicine News(10 mins):Health News:Medication shows mixed results in reducing complications from cardiac surgery 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:LiveStreamingFitness.com is New Trend In Fitness 2Health News:Startling Washington Auto Accident Statistics Discussed In Recently Released Article By The Jones Firm 2
... Va., Nov. 16 /PRNewswire/ Dilon Technologies, Inc. a,United ... announces the hiring of Scott Yarde for the ... Development. Scott Yarde joins Dilon to provide ... brings a proven track record with 25,years of ...
... Graduate Institute,(KGI), in partnership with Smith College, today announced ... "Next Generation Bioscience Leaders",forum designed to help women managers ... will be held Jan. 13-18, 2008. Registration for,the event ... together so many senior executives in the life,science industry ...
... 16 Robbins & Myers, Inc.,(NYSE: RBN ) ... Stearns,3rd Annual Commodities and Capital Goods Conference in New ... and Chief Executive Officer,and Christopher M. Hix, Vice President ... The Company,s presentation is set for 2:00-2:25 p.m., ...
... than 3,000 years old , , FRIDAY, Nov. 16 (HealthDay News) ... ever of human chocolate consumption in pottery vessels more than ... have contained a fermented chocolate concoction -- date from 1150 ... now Puerto Escondido, Honduras. , "It appears to have been ...
... LANDOVER, Md., Nov. 16 According to ... Treatment Study on,Attention-Deficit/Hyperactivity Disorder (MTA) in the ... Academy of Child and Adolescent Psychiatry,(JAACAP), children ... carefully,managed medication alone or in combination with ...
... Disclosures for Separate Account J, WASHINGTON, Nov. ... a Department of Labor investigation, launched in 2002,regarding ... of 1974 (ERISA). The Department of Labor ... pension plan, ultimately focused on whether the compensation,arrangements ...
Cached Medicine News:Health News:Dilon Technologies Appoints New VP of Sales & Business Development 2Health News:KGI and Smith College Announce Speakers for Women Leadership Forum in Bioscience 2Health News:KGI and Smith College Announce Speakers for Women Leadership Forum in Bioscience 3Health News:Chocolate Craving Has Ancient Roots 2Health News:Chocolate Craving Has Ancient Roots 3Health News:ULLICO Inc. and U.S. Department of Labor Agree to Resolve 5 Year Old ERISA Investigation 2Health News:ULLICO Inc. and U.S. Department of Labor Agree to Resolve 5 Year Old ERISA Investigation 3
Steel Knife with box for the Series 8000 Sliding Microtome. C-Profile, 240 x 33 x13m, 22 Degree angle, tapped to accept holder for Shandon knife sharpener....
... M3500 Radial Microtome has a look that is ... range of functions and capabilities that will please ... years of experience and knowledge but still breaking ... M3500 Microtome will be the answer to many ...
Clock oil, 6 grams net...
Coarse abrasive for knife sharpening, 6 grams net...
Medicine Products: